Capital World Investors 13D and 13G filings for Quince Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-07-08 12:56 pm Sale |
2022-07-11 | 13G | Quince Therapeutics, Inc. QNCX |
Capital World Investors | 0 0.000% |
-2,501,882 (Position Closed) |
Filing |
| 2022-02-11 2:48 pm Sale |
2022-02-14 | 13G | Quince Therapeutics, Inc. QNCX |
Capital World Investors | 2,501,882 8.400% |
-668,849 (-21.09%) |
Filing |
| 2021-03-10 2:10 pm Purchase |
2021-03-10 | 13G | Quince Therapeutics, Inc. QNCX |
Capital World Investors | 3,170,731 10.700% |
560,494 (+21.47%) |
Filing |
| 2021-02-16 12:34 pm Purchase |
2021-02-16 | 13G | Quince Therapeutics, Inc. QNCX |
Capital World Investors | 2,610,237 8.800% |
2,610,237 (New Position) |
Filing |